A PHASE 2 .. STUDY TO EVALUATE THE RESPONSE TO & SAFETY OF AN 8-DAY COURSE OR PHEONOPTIN TREATMENT IN SUBJECTS WITH PHENYLKETONURIA WHO HAVE ELEVATED PHENYLALANINE LEVELS
|Effective start/end date||6/10/04 → 12/31/09|
- BIOMARIN PHARMACEUTICAL, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.